218 results
-
List item
Human medicine European public assessment report (EPAR): Bonviva
ibandronic acid, Osteoporosis, Postmenopausal
Date of authorisation: 23/02/2004, Revision: 29, Authorised, Last updated: 02/08/2022Bonviva Musculoskeletal Diseases Bone … Bonviva … summary for the public Bonviva ibandronic acid This is … -
List item
Human medicine European public assessment report (EPAR): Ibandronic acid Accord (updated)
ibandronic acid, Wounds and Injuries; Breast Diseases; Neoplastic Processes; Calcium Metabolism Disorders; Water-Electrolyte Imbalance
Date of authorisation: 18/11/2012,
, Revision: 14, Authorised, Last updated: 05/01/2023
Accord are Bondronat and Bonviva. How is Ibandronic acid Accord … medicines, Bondronat and Bonviva, and do not need to be repeated … comparable to Bondronat and Bonviva. Therefore, the Agency’s … -
List item
National expert: Paolo Porcelli, Italian Medicines Agency (updated)
- Declaration of interests - 79.77 KB | PDF
- Curriculum Vitae - 29.58 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Ibandronic Acid Teva
ibandronic acid, Breast Neoplasms; Neoplasm Metastasis; Fractures, Bone; Osteoporosis, Postmenopausal
Date of authorisation: 17/09/2010,, Revision: 12, Authorised, Last updated: 22/11/2022
Acid Teva are Bondronat and Bonviva. What is Ibandronic Acid Teva … bioequivalent to Bondronat and Bonviva. Therefore, the Committee … that, as for Bondronat and Bonviva, the benefit outweighs the … -
List item
National expert: Eraldo Donnarumma, Italian Medicines Agency (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 17.98 KB | PDF
PANORAMI E PERCORSI) "Doping: soluzione o inganno chimico? (BIF n.4/2006 … PERCORSI) "Il corretto uso delle erbe medicinali" (BIF … -
List item
National expert: Paola Minghetti, Italian Medicines Agency (updated)
- Declaration of interests - 81.41 KB | PDF
- Curriculum Vitae - 62.13 KB | PDF
-
List item
Veterinary medicine European public assessment report (EPAR): Convenia
cefovecin (as sodium salt), Dogs; Cats
Date of authorisation: 19/06/2006, Revision: 13, Authorised, Last updated: 08/12/2020Usobacterium … -
List item
Press release: European Medicines Agency concludes class review of bisphosphonates and atypical fractures
CHMP, Last updated: 15/04/2011Adrovance, Bondenza, Bondronat, Bonviva, Fosavance, Ibandronic acid … Adrovance, Bondenza, Bondronat, Bonviva, Fosavance, Ibandronic acid … -
List item
Direct healthcare professional communications
Last updated: 14/02/2020 -
List item
Press release: European Medicines Agency finalises review of medicines concerned by Roche pharmacovigilance inspection
Last updated: 19/11/2013Avastin, Bondenza, Bondronat, Bonviva, Cellcept, Fuzeon, Heceptin … Avastin, Bondenza, Bondronat, Bonviva, Cellcept, Fuzeon, Heceptin … -
List item
Press release: European Medicines Agency starts infringement procedure to investigate Roche's alleged non-compliance with pharmacovigilance obligations
Last updated: 23/10/2012Roche): EPAR Bondronat: EPAR Bonviva: EPAR CellCept: EPAR Fuzeon … Avastin, Bondenza, Bondronat, Bonviva, Cellcept, Fuzeon, Herceptin … -
List item
Referral: Bisphosphonates
alendronic acid, clodronic acid, etidronic acid, ibandronic acid, neridronic acid, pamidronic acid, risedronic acid, tiludronic acid, zoledronic acid, associated names: Actonel, Aredia, Bonefos, Didronel, Fosamax, Nerixia, Skelid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 13/07/2011, Last updated: 28/10/2011Bondenza: EPAR Bondronat: EPAR Bonviva: EPAR Fosavance: EPAR Ibandronic … zoledronic acid), Bondenza, Bonviva, Bondronat and Ibandronic … Adrovance, Bondenza, Bondronat, Bonviva, Fosavance, Ibandronic acid … -
List item
National expert: Maria Jose Otero Lopez, European Medicines Agency (updated)
- Declaration of interests - 79.94 KB | PDF
- Curriculum Vitae - 23.19 KB | PDF
coordinator). Recomendaciones para el Uso Seguro del Potasio Intravenoso … SENSAR) e Instituto para el Uso Seguro de los Medicamentos … Lopez Organisation/Company: Instituto para el Uso Seguro de los Medicamentos Country … -
List item
National expert: Raffaella Sardelli, Italian Medicines Agency (updated)
- Declaration of interests - 80.05 KB | PDF
- Curriculum Vitae - 22.93 KB | PDF
quot;Contaminazione da alluminio in soluzioni di albumina umana: un monitoraggio … dell'attivatore della precallicreina in soluzioni di albumina umana" (Abs … -
List item
National expert: Emilia Cercenado Mansilla, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 80.77 KB | PDF
- Curriculum Vitae - 247.46 KB | PDF
-
List item
National expert: Giuseppina Ialongo, Italian Medicines Agency (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 20.14 KB | PDF
Roma Aprile 1998, Seminario Interno U. O. Gruppo Grandi Rischi … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 21-24 June 2010
CHMP, Last updated: 25/06/2010Teva 150 mg* is a generic of Bonviva. … 150 mg* is a generic of Bonviva. • Telmisartan Actavis … -
List item
Human medicine European public assessment report (EPAR): Fampyra
Fampridine, Multiple Sclerosis
Date of authorisation: 20/07/2011, Revision: 16, Authorised, Last updated: 05/05/2022 -
List item
National expert: Armando Magrelli, Italian Medicines Agency (updated)
- Declaration of interests - 79.81 KB | PDF
- Curriculum Vitae - 29.06 KB | PDF
Agency http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000049.jsp&mid=WC0b01ac05800229b9 http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000094.jsp&mid=WC0b01ac0580028c79 http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000094.jsp&mid=WC0b01ac0580028c79 http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000049.jsp&mid=WC0b01ac05800229b9 Con Soluzioni Con Srl (Italy) Main activities … -
List item
National expert: Francesca Rocchi, Italian Medicines Agency (updated)
- Declaration of interests - 81.55 KB | PDF
- Curriculum Vitae - 27.96 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Cinryze
C1 inhibitor (human), Angioedemas, Hereditary
Date of authorisation: 15/06/2011,
, Revision: 23, Authorised, Last updated: 10/10/2022
-
List item
National expert: Antonio Portolés, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 82.88 KB | PDF
- Curriculum Vitae - 43.11 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Bavencio
avelumab, Neuroendocrine Tumors
Date of authorisation: 18/09/2017,, Revision: 14, Authorised, Last updated: 19/10/2022
-
List item
National expert: Henrique Ramos da Costa, General Directorate of Food and Veterinary (updated)
- Declaration of interests - 80.03 KB | PDF
- Curriculum Vitae - 17.18 KB | PDF
medicamentos e outros produtos de uso veterinario: Sistema Nacional … medicamentos e outros produtos de uso veterinario: Sistema Nacional … medicamentos e outros produtos de uso veterinario: Sistema Nacional … -
List item
Human medicine European public assessment report (EPAR): Invirase
saquinavir, HIV Infections
Date of authorisation: 03/10/1996, Revision: 49, Authorised, Last updated: 20/10/2022